Lianyungang Jerry Pharmaceutical

Lianyungang Jerry Pharmaceutical is a specialized pharmaceutical company based in Lianyungang, China, operating as a subsidiary of the 716th Research Institute of China State Shipbuilding Corporation (CSSC). The company focuses on the development, manufacture, and global distribution of high-potency active pharmaceutical ingredients (APIs) and finished dosage forms, primarily in the oncology therapeutic area. Its manufacturing facilities are designed to meet international quality standards, having successfully passed inspections by the US FDA, EU GMP, and China NMPA. Jerry Pharmaceutical is recognized for its expertise in complex chemical synthesis, producing key products such as Irinotecan, Topotecan, and Temozolomide. Beyond its internal portfolio, the company serves as a CDMO partner for pharmaceutical firms seeking high-quality production of cytotoxic and non-cytotoxic drugs.